Tags
Language
Tags
<<
July 2025
Su Mo Tu We Th Fr Sa
29 30 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2
    Attention❗ To save your time, in order to download anything on this site, you must be registered 👉 HERE. If you do not have a registration yet, it is better to do it right away. ✌
    https://sophisticatedspectra.com/article/drosia-serenity-a-modern-oasis-in-the-heart-of-larnaca.2521391.html

    DROSIA SERENITY
    A Premium Residential Project in the Heart of Drosia, Larnaca
    ONLY TWO FLATS REMAIN!

    Modern and impressive architectural design with high-quality finishes Spacious 2-bedroom apartments with two verandas and smart layouts Penthouse units with private rooftop gardens of up to 63 m² Private covered parking for each apartment Exceptionally quiet location just 5–8 minutes from the marina, Finikoudes Beach, Metropolis Mall, and city center Quick access to all major routes and the highway Boutique-style building with only 8 apartments High-spec technical features including A/C provisions, solar water heater, and photovoltaic system setup.
    Drosia Serenity is not only an architectural gem but also a highly attractive investment opportunity. Located in the desirable residential area of Drosia, Larnaca, this modern development offers 5–7% annual rental yield, making it an ideal choice for investors seeking stable and lucrative returns in Cyprus' dynamic real estate market. Feel free to check the location on Google Maps.
    Whether for living or investment, this is a rare opportunity in a strategic and desirable location.

    1. Home
    2. Magazines
    3. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, Classification, and Stratification

    K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, Classification, and Stratification

    Posted By: hotspot
    Date: 23 Jul 2006 06:50:00
    K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification


    Foreword

    Part 1. Executive Summary

    Part 2. Background

    Part 3. Chronic kidney disease as a public health problem

    Part 4. Definition and classification of stages of chronic kidney disease
    Guideline 1. Definition and Stages of Chronic Kidney Disease
    Guideline 2. Evaluation and Treatment
    Guideline 3. Individuals at Increased Risk of Chronic Kidney Disease

    Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease
    Guideline 4. Estimation of GFR
    Guideline 5. Assessment of Proteinuria
    Guideline 6. Markers of Chronic Kidney Disease Other Than Proteinuria

    Part 6. Association of level of GFR with complications in adults
    Guideline 7. Association of Level of GFR With Hypertension
    Guideline 8. Association of Level of GFR With Anemia
    Guideline 9. Association of Level of GFR With Nutritional Status
    Guideline 10. Association of Level of GFR With Bone Disease and Disorders of Calcium and Phosphorus Metabolism
    Guideline 11. Association of Level of GFR With Neuropathy
    Guideline 12. Association of Level of GFR With Indices of Functioning and Well-Being

    Part 7. Stratification of risk for progression of kidney disease and development of cardiovascular disease
    Guideline 13. Factors Associated With Loss of Kidney Function in Chronic Kidney Disease
    Guideline 14. Association of Chronic Kidney Disease With Diabetic Complications
    Guideline 15. Association of Chronic Kidney Disease With Cardiovascular Disease

    Part 8. Recommendations for clinical performance measures

    Part 9. Approach to chronic kidney disease using these guidelines

    Part 10. Appendices
    Appendix 1. Methods for Review of Articles
    Appendix 2. Kidney Function and Associated Conditions in the United States: Methods and Findings From the Third National Health and Nutrition Examination Survey (1988 to 1994)
    Appendix 3. Methodological Aspects of Evaluating Equations to Predict GFR and Calculations Using 24-Hour Urine Samples

    Part 11. Work group members

    Part 12. Acknowledgements

    Bibliography

    download here
    (please no oxyshare)
    UPWARDS